当前位置:
X-MOL 学术
›
Expert Rev. Clin. Immunol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
How to and should we target EBV in MS?
Expert Review of Clinical Immunology ( IF 4.4 ) Pub Date : 2024-03-13 , DOI: 10.1080/1744666x.2024.2328739 Svetlana Eckert 1 , Dejan Jakimovski 1, 2 , Robert Zivadinov 2, 3 , Mark Hicar 4 , Bianca Weinstock-Guttman 1
Expert Review of Clinical Immunology ( IF 4.4 ) Pub Date : 2024-03-13 , DOI: 10.1080/1744666x.2024.2328739 Svetlana Eckert 1 , Dejan Jakimovski 1, 2 , Robert Zivadinov 2, 3 , Mark Hicar 4 , Bianca Weinstock-Guttman 1
Affiliation
The etiology of multiple sclerosis (MS) remains unknown. Pathogenesis likely relies on a complex interaction between multiple environmental, genetic, and behavioral risk factors. However, a growing...
中文翻译:
我们应该如何以及应该针对 MS 中的 EBV 进行治疗?
多发性硬化症 (MS) 的病因仍不清楚。发病机制可能依赖于多种环境、遗传和行为风险因素之间复杂的相互作用。然而,越来越多的...
更新日期:2024-03-13
中文翻译:
我们应该如何以及应该针对 MS 中的 EBV 进行治疗?
多发性硬化症 (MS) 的病因仍不清楚。发病机制可能依赖于多种环境、遗传和行为风险因素之间复杂的相互作用。然而,越来越多的...